North America leads the global radiofrequency ablation devices market with a share of 45.3% in 2014 that translated into revenues worth US$ 1,421.8 million.
North America has the largest acceptance for radiofrequency ablation procedures in cardiac arrhythmia, gynecology, tumor management and pain management. The demand for RF based ablation devices is however slowly being replaced by other technologies such as ultrasound, cryoablation and microwave abla...
